In a funk after years of stagnation and high unemployment, Germany is looking to an unlikely alliance between football and R&D to kick start the economy.
Napatech, a Danish company that specialised in raising the speed of Internet network appliances, said it has received $5 million from Ferd Venture, Northzone Ventures and existing shareholder DTU Innovation, a fund which is related to the Danish Technical University.
Who should benefit from the transfer of technology from the academic world into the business arena? The university that cooked up the ideas, or the company that turned them into money? How about society as a whole? An American Prof warns against micro managing the process.
Microsoft has stepped up its courtship of the international research community with the publication of an investigation of how computer science will underpin scientific discovery in the next 15 years.
Tectonic shifts in the patent landscape could follow on from high-profile lawsuits challenging what can be protected by a patent and how patents are enforced that are due to be heard by the US Supreme Court this month.
The competition to lure biotech investors and know-how is heating up in US states - and so are the legal battles between over fair and unfair incentives.
Retina Implant AG has developed an electronic chip that is implanted in the eye under the retina and could restore partial vision for the blind – and is now looking for funding from investors to take the product to the market next year.
Friedrich Bornikoel, managing partner for TVM Capital's Information & Communications Technology group, sees a recovery in German venture capital - but still no boom.
Chameleon BioSurfaces, a spin-out from the John Innes Centre in Norwich, UK, is looking for £500,000 in funding to develop a new form of polymer coating for drug eluting stents.
Europe's aversion to GM crops has killed investors' appetites for agricultural research. Even in the UK, historically a world leader in this field, it is almost impossible to commercialise agricultural biotechnology of any kind.
If Europe's economy is to prosper into the 21st Century, it needs to get more ideas out of its famous university labs and into its commercial markets. A high-level meeting of academia, industry and government, organized by Science|Business.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.